multiple myeloma - Robuta Search

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-talquetamab-tgvs-relapsed-or-refractory-multiple-myeloma FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma |... On August 9, 2023, the Food and Drug Administration granted accelerated approval to talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) multiple myeloma fda grants accelerated approval https://blackdoctor.com/best-multiple-myeloma-treatment-option/ What Is Your Best Multiple Myeloma Treatment Option? - BlackDoctor Mar 7, 2026 - What Is Your Best Multiple Myeloma Treatment Option? Find out what is multiple myeloma and are treatment options are best for you! what is multiple myeloma treatment option best blackdoctor https://ecancer.org/en/news/23180-asco-2023-ciltacabtagene-autoleucel-reduces-risk-of-disease-progression-by-74-in-multiple-myeloma-after-lenalidomide-stops-working ASCO 2023: Ciltacabtagene autoleucel reduces risk of disease progression by 74% in multiple myeloma... Ciltacabtagene autoleucel, a BCMA-targeting CAR T-cell therapy, significantly slows or stops progression of multiple myeloma when compared with standard-of-care disease progression multiple myeloma asco risk https://ctv.veeva.com/study/a-phase-1-open-label-multicenter-dose-escalation-study-of-the-safety-tolerability-and-pk-of-hpn2 Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) Researchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of this study are to learn... multiple myeloma study participants refractory mk https://www.cancernetwork.com/view/bloodless-transplant-feasible-multiple-myeloma Is Bloodless Transplant Feasible in Multiple Myeloma? | CancerNetwork May 19, 2026 - Undergoing bloodless autologous stem cell transplantation could be a viable option for some multiple myeloma patients according to a retrospective study. multiple myeloma bloodless transplant cancernetwork https://curemydisease.com/studies/dreamm-2-belantamab-for-multiple-myeloma-nct03525678-554 DREAMM 2: Belantamab for Multiple Myeloma (NCT03525678) A phase 2 study testing two doses of belantamab mafodotin in adults with advanced multiple myeloma who have tried multiple prior treatments. NCT ID:... multiple myeloma dreamm https://int.livhospital.com/hematology/multiple-myeloma/india/ Multiple Myeloma Treatment Cost in India vs Turkey Explore Multiple Myeloma Treatment cost in India and compare it with Turkey options for Indian patients. Compare local prices with Turkey and discover your... multiple myeloma treatment cost india vs turkey https://cancer.osu.edu/blog/patient-becomes-donor-to-help-find-cure-for-multiple-myeloma Patient Becomes Donor to Help Find Cure for Multiple Myeloma A multiple myeloma patient is taking an active role in the effort to find a cure for the illness. to help multiple myeloma patient becomes donor https://www.walkuplawoffice.com/2025/07/02/kaiser-result-failure-to-diagnose-multiple-myeloma/ Kaiser Result: Failure to Diagnose Multiple Myeloma - Walkup, Melodia, Kelly & Schoenberger Jul 3, 2025 - Confidential Settlement The Walkup Kaiser negligence group negotiated a settlement for a 56-year-old patient who developed kidney failure and required lifetime... failure to diagnose multiple myeloma kaiser result melodia https://www.creative-bioarray.com/products/multiple-myeloma-fish-probes-list-530.htm Multiple Myeloma FISH Probes - Creative Bioarray | Creative Bioarray Multiple Myeloma FISH probes from Creative Bioarray are specialized research tools designed to detect genetic abnormalities associated with multiple myeloma, a... multiple myeloma fish probes creative https://scholars.houstonmethodist.org/en/publications/bone-marrow-stromal-cells-derived-mcp-1-reverses-the-inhibitory-e/ Bone marrow stromal cells derived MCP-1 reverses the inhibitory effects of multiple myeloma cells... bone marrow multiple myeloma cells derived mcp https://www.muni.cz/vyzkum/publikace/1107535 Cell Cycle Genes Coexpression in Multiple Myeloma and Plasma Cell Leukemia | Masarykova univerzita... cell cycle multiple myeloma masarykova univerzita genes plasma https://www.texasoncology.com/cancer-care/multiple-myeloma/stages Stages of Multiple Myeloma | Texas Oncology Multiple myeloma is staged from I to III based on tumor burden and lab values. Texas Oncology provides expert care, including diagnosis, treatment, and support. stages of multiple myeloma texas oncology https://www.dana-farber.org/for-physicians/clinical-resources/hematologic-malignancies/advances-newsletter/2013-issue-2/patient-care-spotlight-hypercalcemia-multiple-myeloma Patient Care Spotlight: Current Management of Hypercalcemia Associated With Multiple Myeloma |... Discover the latest patient care spotlight on hypercalcemia associated with multiple myeloma and how Dana-Farber is improving patient outcomes. patient care associated with multiple myeloma spotlight current https://peoplebeatingcancer.org/multiple-myeloma-darzalex-best-among-all-triplet-combinations/ Multiple Myeloma- Darzalex Best Among All Triplet Combinations - PeopleBeatingCancer Feb 1, 2022 - Since only two agents were found to add a significant cost-effective value to multiple myeloma regimens, the researchers highlighted the need for improved multiple myeloma best among triplet combinations https://scholars.hkmu.edu.hk/en/publications/cardiovascular-toxicity-of-proteasome-inhibitors-in-multiple-myel/fingerprints/ Cardiovascular Toxicity of Proteasome Inhibitors in Multiple Myeloma Therapy - Fingerprint - Hong... proteasome inhibitors multiple myeloma cardiovascular toxicity therapy https://scholars.mssm.edu/en/clippings/fda-approves-carvykti-as-second-car-t-cell-therapy-for-advanced-m/ FDA approves Carvykti as second CAR T-cell therapy for advanced multiple myeloma - Icahn School of... car t cell therapy for advanced multiple myeloma fda https://www.healthwellfoundation.org/realworldhealthcare/tag/multiple-myeloma/ multiple myeloma Archives - HealthWell Foundation multiple myeloma healthwell foundation archives https://www.aitia.com/investigation-of-mechanisms-of-response-in-multiple-myeloma-via-bayesian-causal-inference-an-early-analysis-of-the-commpass-study-data/ Investigation of Mechanisms of Response in Multiple Myeloma Via Bayesian Causal Inference: An Early... Nov 23, 2023 - Fred Gruber, Boris Hayete, Jonathan Keats, Kyle McBride, Karl Runge, Mary DeRome, Sagar Lonial, Iya Khalil, Daniel Auclair. American Society of Hematology... multiple myeloma causal inference investigation mechanisms response https://healthtree.org/myeloma/community/events/virtual-round-table-may-2020 Roundtable Empowers Patients for Better Outcomes - HealthTree for Multiple Myeloma Myeloma Patient and Expert Roundtable Empowers Patients for Better Outcomes better outcomes multiple myeloma roundtable patients https://stanfordhealthcare.org/trials/h/NCT00349778.html High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma Stanford Health Care delivers the highest levels of care and compassion. SHC treats cancer, heart disease, brain disorders, primary care issues, and many more. high dose multiple myeloma sequential therapy single https://kanker-actueel.nl/NL/algemeen-kahler-multiple-myeloma-informatie.html Algemeen: Kahler - Multiple Myeloma informatie Algemeen: Kahler - Multiple Myeloma informatie multiple myeloma algemeen kahler informatie https://pubmed.ncbi.nlm.nih.gov/35177759/ Time trend and Bayesian mapping of multiple myeloma incidence in Sardinia, Italy A few reports have described increasing trends and spatial distribution of multiple myeloma (MM). We used a validated database including the 1606 cases of MM... multiple myeloma time trend bayesian mapping https://researchrepository.ucd.ie/entities/publication/4e011e76-dd6f-4f60-8e8e-b2911d30eac3 An investigation into Extracellular Vesicles content and function within the Multiple Myeloma... Multiple myeloma (MM) is an incurable blood cancer that results from the monoclonal expansion of plasma cells in the bone marrow (BM). The progression of MM... an investigation extracellular vesicles the multiple content function https://bpno.no/medtalks/a-potential-new-standard-of-care-for-transplant-eligible-patients-with-multiple-myeloma/ A potential new standard of care for transplant-eligible patients with Multiple Myeloma Aug 5, 2024 - Pieter Sonneveld discussed in this MEDtalk the PERSEUS trial presented at ASH 2023. The study involved 700 patients across 13 countries and showed promising... standard of care multiple myeloma potential new transplant https://cancerchat.cancerresearchuk.org/f/caring-for-someone-with-cancer/129048/my-sister-s-just-been-diagnosed-with-multiple-myeloma-how-can-i-best-support-her-both-physically-and-emotionally My Sister's just been diagnosed with multiple myeloma. How can I best support her both, physically... My Sister was diagnosed with Multiple Myeloma 8 days ago, our family and close friends feel very concerned and worried for her. She is on lots of strong meds... just been diagnosed multiple myeloma sister best support https://arizonaccc.com/service/multiple-myeloma/ Multiple Myeloma - Arizona Center for Cancer Care multiple myeloma cancer care arizona center https://www.siemens-healthineers.com/hu/plasma-protein/webinars/flc-testing-multiple-myeloma-kidney-disease-chinese-perspective FLC testing in multiple myeloma and kidney disease: A Chinese Perspective - Siemens Healthineers... This session explores a Chinese perspective on the current role of FLC testing in MM, and considers the influence of kidney function on FLC test result. multiple myeloma kidney disease siemens healthineers flc testing https://www.panabee.com/news/arcellx-announces-positive-phase-2-data-for-multiple-myeloma-treatment Arcellx Announces Positive Phase 2 Data for Multiple Myeloma Treatment | ACLX Financial News Arcellx announced positive Phase 2 clinical trial data for its multiple myeloma treatment, anito-cel, and will present updated data at the American Society of... multiple myeloma financial news arcellx announces positive https://medcode.ch/ca/en/icds/ICD-10-CM-2018/C90 ICD-10-CM 2018: C90 Multiple myeloma and malignant plasma cell neop... multiple myeloma icd cm malignant plasma https://researchportal.vub.be/nl/publications/unveiling-b7-h3-as-novel-target-for-car-t-cell-therapy-in-multipl/ Unveiling B7-H3 as novel target for CAR T-cell therapy in Multiple Myeloma - Vrije Universiteit... for car cell therapy multiple myeloma vrije universiteit unveiling https://research.universityofgalway.ie/en/publications/multiple-myeloma-and-other-differentiated-b-cell-disorders-3/ Multiple myeloma and other differentiated B-cell disorders. - University of Galway university of galway multiple myeloma b cell disorders https://outcomes4me.com/patient/community/Surgery-and-Recovery/post/escuzr/multiple-myeloma-affect-vision-hearing Does multiple myeloma affect vision or hearing? | Outcomes4Me Community Does anyone have multiple myeloma? Does it affect your vision, or hearing? multiple myeloma affect vision hearing community https://research.tilburguniversity.edu/en/publications/chemotherapy-induced-neuropathy-in-multiple-myeloma-influence-on-/ Chemotherapy-induced neuropathy in multiple myeloma: Influence on quality of life and development... quality of life multiple myeloma chemotherapy neuropathy influence https://kris.kl.ac.at/en/publications/cure-for-multiple-myeloma/ Cure for multiple myeloma? - Karl Landsteiner University multiple myeloma karl landsteiner cure university https://pure.fujita-hu.ac.jp/ja/publications/prediction-of-mobilized-hematopoietic-stem-cell-yield-in-patients/ Prediction of mobilized hematopoietic stem cell yield in patients with multiple myeloma: Usefulness... stem cell in patients multiple myeloma prediction yield https://www.bioworld.com/articles/720805-ldhal6b-identified-as-a-prognostic-biomarker-in-multiple-myeloma?v=preview LDHAL6B identified as a prognostic biomarker in multiple myeloma | BioWorld Multiple myeloma (MM) is a complex and heterogeneous blood cancer, and current risk assessment tools like the Revised International Staging System (R-ISS) have... as a multiple myeloma identified biomarker bioworld https://avesis.hacettepe.edu.tr/yayin/641b24be-8ffc-42d9-8848-b5f8ac9019e4/evaluation-of-the-survival-outcomes-of-multiple-myeloma-patients-according-to-their-plasmacytoma-presentation-at-diagnosis Evaluation of the Survival Outcomes of Multiple Myeloma Patients According to Their Plasmacytoma... survival outcomes multiple myeloma according to evaluation patients https://einstein.elsevierpure.com/en/publications/characterization-of-central-nervous-system-multiple-myeloma-in-th/ Characterization of central nervous system multiple myeloma in the era of novel therapies - Albert... central nervous system multiple myeloma the era novel therapies characterization https://multiplemyeloma.org.nz/zoom-catch-up-support-group/ Zoom catch up/support group | Multiple Myeloma catch up support group multiple myeloma zoom https://www.frontiersin.org/research-topics/71130/advances-in-immunotherapy-and-molecular-characterization-of-multiple-myeloma/authors Frontiers | Advances in Immunotherapy and Molecular Characterization of Multiple Myeloma Multiple myeloma (MM) remains a complex and heterogeneous hematologic malignancy with evolving therapeutic challenges. In recent years, immunotherapy has eme... multiple myeloma frontiers advances immunotherapy molecular https://ubiehealth.com/doctors-note/period-back-pain-multiple-myeloma Could multiple myeloma be the reason for increased back pain during my period? | Ubie Doctor's Note Increased back pain during your period is often linked to menstrual disorders and not typically to multiple myeloma. be the reason multiple myeloma back pain could increased https://haematologica.org/article/view/7399 Health-related quality of life in patients with multiple myeloma - does it matter? | Haematologica quality of life health related in patients multiple myeloma matter https://www.birminghammedicalnews.com/article/9377/men-more-likely-to-develop-multiple-myeloma-than-women Men More Likely to Develop Multiple Myeloma than Women - Birmingham Medical News Multiple myeloma, the second most common blood cancer in the United States, is more common in men with an estimated 20,030 new male cases in 2025. The reasons... more likely multiple myeloma medical news men develop https://www.cancercare.org/questions/tagged/multiple_myeloma Multiple Myeloma, Treatments Experts answer questions about multiple myeloma treatments, your diagnosis and other cancer related questions. multiple myeloma treatments https://www.aacr.org/blog/2015/03/03/fda-approval-panobinostat-epigenetic-targeted-therapeutic/ Epigenetic Research Yields New Multiple Myeloma Therapeutic - American Association for Cancer... Mar 3, 2015 - The FDA recently approved a new epigenetic-targeted therapeutic called panobinostat (Farydak) for certain patients with multiple myeloma. multiple myeloma american association epigenetic research yields https://www.jadpro.com/issues/volume-5-number-3-mayjun-2014/innovative-agents-in-multiple-myeloma/ JADPRO | Innovative Agents in Multiple Myeloma multiple myeloma innovative agents https://secure.medicalletter.org/TML-article-1495d Three New Drugs for Multiple Myeloma (online only) | The Medical Letter Inc. The Medical Letter has provided trusted prescription drug information and drug facts since 1959 new drugs multiple myeloma online only three medical https://www.jci.org/assets/324189/powerpoint JCI - Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells multiple myeloma jci antibody drug conjugate https://bloodjournal.ru/index.php/coh/en/article/view/36?articlesBySameAuthorPage=3 Efficacy of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients Aged... stem cell transplantation multiple myeloma efficacy autologous patients https://www.uc.edu/news/articles/2024/03/everyday-health--ways-to-manage-symptoms-linked-to-multiple-myeloma.html EveryDay Health: Ways to manage symptoms linked to multiple myeloma - University of Cincinnati:... Mar 26, 2024 - The University of Cincinnati's Ed Faber spoke with EveryDay Health about ways to manage symptoms of multiple myeloma including numbness, pain or tingling in... university of cincinnati everyday health manage symptoms multiple myeloma ways https://www.oaepublish.com/articles/cdr.2018.04 Drug targets and resistance mechanisms in multiple myeloma Multiple myeloma (MM), a malignancy of plasma cells, is the second most prevalent blood cancer (10%). A PubMed search has been conducted for English research... drug targets multiple myeloma resistance mechanisms https://www.sciencedaily.com/releases/2007/08/070813121034.htm Molecular Mechanisms In Multiple Myeloma Illluminated: Could Lead To More Effective Therapies |... Two new studies may lead to the development of more effective therapies for individuals with multiple myeloma, a common and incurable blood cell cancer. The... multiple myeloma lead to molecular mechanisms could https://scholarworks.utrgv.edu/som_pub/1387/ "When Two Worlds Collide: A Rare Case of Multiple Myeloma With Extramed" by Jorge Nadal Bosch,... In this case report, we discuss the presentation, diagnosis, and management of a 67-year-old gentleman with stage II multiple myeloma with concurrent... two worlds multiple myeloma collide rare case https://file.scirp.org/Html/23392.html New antimyeloma drugs in spinal cord infiltration for multiple myeloma. Determination of... A 64-year-old woman with IgA kappa multiple myeloma was treated with thalidomide-dexa- methasone. Due to progression of the disease, bortezomib, doxorubicin... spinal cord multiple myeloma new drugs infiltration https://uamshealth.com/clinical-resource/van-rhee-car-t-cell-therapy-myeloma/ Dr. Van Rhee on Future Research Directions for CAR T-Cell Therapy in Multiple Myeloma | UAMS Health A significant question that remains with CAR T-cell therapy in for patients with multiple myeloma is where it fits into the treatment algorithm. future research for car cell therapy multiple myeloma uams health https://indianjnephrol.org/abo-incompatible-renal-allograft-in-a-patient-with-multiple-myeloma/ ABO-Incompatible Renal Allograft in a Patient with Multiple Myeloma - A Case Report - Indian... Nov 8, 2025 - ABO-Incompatible Renal Allograft in a Patient with Multiple Myeloma in a multiple myeloma case report abo incompatible https://fair.unifg.it/handle/11369/434640 LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing... as a bone disease multiple myeloma light new https://blood-cancer.com/clinical/sre-multiple-myeloma Managing Multiple Myeloma Skeletal-Related Events Multiple myeloma can lead to bone disease and skeletal-related events that may include bone pain, fractures, and spinal cord compression, and hypercalcemia. multiple myeloma related events managing skeletal https://mediamedic.co/bispecific-car-t-cell-therapy-targeting-bcma-and-cd19-in-relapsed-refractory-multiple-myeloma-a-phase-i-ii-clinical-trial/ Bispecific CAR T Cell Therapy Targeting BCMA and CD19 in Relapsed/Refractory Multiple Myeloma: A... May 23, 2024 - In the evolving landscape of hematology and oncology, innovative treatments for challenging conditions like relapsed or refractory multiple myeloma (R/R MM)... car t cell therapy multiple myeloma bispecific targeting https://iris.unical.it/handle/20.500.11770/402999 Relapse Despite MRD Negativity in Multiple Myeloma: Toward Integrated Risk Prediction multiple myeloma risk prediction relapse despite mrd https://eahp.eu/gpi_submission/adequacy-and-effectiveness-thromboembolic-prophylaxis-multiple-myeloma-patients-treated/ Adequacy and effectiveness of thromboembolic prophylaxis in multiple myeloma patients treated with... Jul 9, 2024 - The European Association of Hospital Pharmacists represents more than 27.000 hospital pharmacists in 36 European countries and is the only association of... multiple myeloma adequacy effectiveness prophylaxis patients https://repository.icr.ac.uk/items/e8ff340c-4f7f-4a01-b994-618071875b06 Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically... Multiple myeloma (MM) is a biologically heterogeneous malignancy, however, the mechanisms underlying this complexity are incompletely understood. We report an... whole genome sequencing multiple myeloma reveals pathways targeted https://www.pocn.com/rare-multiple-myeloma-case-in-pregnancy-successfully-managed-with-treatment-leading-to-healthy-delivery-2/ Rare Multiple Myeloma Case in Pregnancy Successfully Managed With Treatment, Leading to Healthy... Apr 9, 2025 - Multiple myeloma (MM) during pregnancy is rare, with only 45 [...] multiple myeloma with treatment leading to rare case https://www.knowcancer.com/cancer-trials/NCT00445484/ Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma RATIONALE: Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Vaccines ma multiple myeloma lenalidomide vaccine therapy treating https://www.oncolink.org/cancers/multiple-myeloma/radiation-therapy-for-multiple-myeloma Radiation Therapy for Multiple Myeloma | OncoLink This article describes why your provider may recommend radiation therapy for multiple myeloma. radiation therapy multiple myeloma https://veri.larvol.com/associations/mcl1-underexpression_multiple-myeloma_bortezomib+a-1331852 Multiple Myeloma - bortezomib + A-1331852 - MCL1 underexpression - LARVOL VERI LARVOL VERI predictive biomarker evidence connecting Multiple Myeloma, bortezomib + A-1331852, and MCL1 underexpression. multiple myeloma veri